Takeda Pharmaceutical
TAK
#393
Rank
NZ$103.43 B
Marketcap
NZ$32.74
Share price
1.94%
Change (1 day)
25.80%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2025 (TTM): NZ$5.55 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are NZ$29.86 Billion. , an increase over its 2024 earnings that were of NZ$3.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2025

Annual earnings

Year Earnings Change
2025 NZ$5.76 B49.03%
2024 NZ$3.86 B-2.41%
2023 NZ$3.96 B-28.14%
2022 NZ$5.51 B-40.9%
2021 NZ$9.33 B78.24%
2020 NZ$5.23 B246.1%
2019 NZ$1.51 B-48.79%
2018 NZ$2.95 B-23.64%
2017 NZ$3.86 B21.7%
2016 NZ$3.17 B-253.01%
2015 -NZ$2.08 Billion-159.65%
2014 NZ$3.48 B13%
2013 NZ$3.08 B2.46%
2012 NZ$3.00 B-57.05%
2011 NZ$7.00 B-10.49%
2010 NZ$7.82 B-3.99%
2009 NZ$8.15 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$58.18 B 908.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$28.35 B 391.69%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$17.67 B 206.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.56 B 169.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$13.35 B 131.51%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$38.88 B 574.24%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.16 B 197.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-NZ$1.38 Billion-123.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
NZ$1.51 B-73.74%๐Ÿ‡ฎ๐Ÿ‡ณ India